#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vitamin B12 deficiency Pouchitis Cutaneous T-cell lymphoma stage II Squamous cell carcinoma of the hypopharynx Malformation venous Extranodal marginal zone B-cell lymphoma (MALT type) Subdural haematoma Hypertriglyceridaemia Extra-osseous Ewing's sarcoma metastatic Short stature homeobox gene mutation Hyperoxaluria Central nervous system neoplasm Gastrointestinal stromal tumour Langerhans cell sarcoma Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Trials in Disease Hepatoblastoma – Treatment Bronchiolitis obliterans syndrome – Treatment Carcinoid syndrome – Trials in Disease Myxofibrosarcoma – Life with Disease Marginal zone lymphoma – Diagnostics Indolent systemic mastocytosis – Treatment Methylmalonic acidaemia – Diagnostics Short-bowel syndrome – Trials in Disease Sjogren’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALE.P02 Acetylcysteine Apocynin Tegafur Skin Autograft Ondansetron Sar-443579 Cabergoline MOLNUPIRAVIR Ergocalciferol Inclisiran Exl01 Keto-Isoleucine Calcium Alendronate Sodium Monohydrate IMB 101 Nido-361 Carmustine Sodium Laurilsulfate Festuca Rubra Pollen Antithymocyte Immunoglobulin More therapies…

    Learn about Your Condition

    Colonoscopy Friedreich's ataxia Breast cancer stage I Delayed graft function Pseudomonas infection Primary biliary cholangitis Naevoid melanoma Diabetes insipidus Erythema Apathy BK virus infection Onychomycosis Mucosal inflammation Actinic keratosis Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    Investigated Drugs:
    • Letrozole
    • Carboplatin
    • Paclitaxel
    Czechia Italy

  • Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Retroviral Vector Containing The Common Gamma Chain Cdna
    The Netherlands

  • Study on the Effects of Alirocumab and Drug Combination on Hyperlipidemia in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperlipidaemia
    Investigated Drugs:
    • Alirocumab
    • Evolocumab
    • Rosuvastatin Zinc
    Austria

  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma recurrent
    • Extra-osseous Ewing’s sarcoma
    • Extra-osseous Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Etoposide Phosphate
    • Anhydrous Docetaxel
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +4

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Germany Italy

  • Study on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    Spain
Previous Page
1 … 300 301 302 303 304 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!